Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NeuBase Therapeutics, Inc. | 10%+ Owner | Common Stock, par value $0.0001 | 192K | $370K | $1.92 | Sep 18, 2023 | Direct |
NeuBase Therapeutics, Inc. | 10%+ Owner | Common Stock, Par Value $0.0001 per Share | 0 | $1.19 | Sep 18, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NBSE | NeuBase Therapeutics, Inc. | Sep 14, 2023 | 3 | -$376K | 4 | Sep 18, 2023 | 10%+ Owner |
NBSE | NeuBase Therapeutics, Inc. | Sep 7, 2023 | 3 | -$337K | 4 | Sep 11, 2023 | 10%+ Owner |
NBSE | NeuBase Therapeutics, Inc. | Sep 1, 2023 | 1 | $59.7K | 4 | Sep 7, 2023 | 10%+ Owner |
NBSE | NeuBase Therapeutics, Inc. | Aug 23, 2023 | 0 | $0 | 3/A | Sep 12, 2023 | 10%+ Owner |
NBSE | NeuBase Therapeutics, Inc. | Dec 31, 2022 | 1 | $0 | 5 | Sep 20, 2023 | no longer 10% Owner |